Zidovudine-induced nail hyper-pigmentation in 45-year-old women prescribed for HIV/tuberculosis co-infection

• Auteurs principaux: Vishal R Tandon (Auteur), Shamiya Sadiq (Auteur), Vijay Khajuria (Auteur), Annil Mahajan (Auteur), Sudhaa Sharma (Auteur), Zahid Gillani (Auteur)
• Format: Livre
• Publié: Wolters Kluwer Medknow Publications, 2016-01-01T00:00:00Z.
• Sujets: article
• Accès en ligne: Connect to this object online.

Zidovudine is an important component of first-line antiretroviral treatment regimens used to manage HIV and tuberculosis (TB) co-infection. Nail pigmentation is documented both in adult as well as pediatric HIV patients, but to the best of our knowledge, it has not been reported in 45-year-old women...